Jci_page_head_homepage_01 Jci_page_head_homepage_02
Tatsuro Ishida, Sungshin Choi, Ramendra K. Kundu, Ken-ichi Hirata, Edward M. Rubin, Allen D. Cooper, Thomas Quertermous
Published in Volume 111, Issue 3
J Clin Invest. 2003; 111(3):347–355 doi:10.1172/JCI16306
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 5

Phospholipase activity in genetic models. Phospholipase activity in different genetic lines was compared between pre- and postheparin injection samples. A significantly greater level of postheparin phospholipase activity was observed in the transgenic lines (*P < 0.05), and a significantly lower level of postheparin augmentation of phospholipase activity was found in the knockout animals (*P < 0.05) as compared to the wild-type controls. The preheparin levels of plasma phospholipase activity were as follows (mean ± SEM): wild-type animals, 519 ± 22.3 nmol FFA/ml/hr; knockout animals, 521 ± 5.4 nmol FFA/ml/hr; and transgenic animals, 510.5 ± 20.2 nmol FFA/ml/hr. PLase, phospholipase activity; Tg, hLIPGTg; KO, LIPG–/–.